---
title: "Vigil Neuroscience (VIGL.US) — Financial Reports"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/VIGL.US/norm.md"
symbol: "VIGL.US"
name: "Vigil Neuroscience"
parent: "https://longbridge.com/en/quote/VIGL.US.md"
datetime: "2026-03-10T04:30:27.359Z"
locales:
  - [en](https://longbridge.com/en/quote/VIGL.US/norm.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/VIGL.US/norm.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/VIGL.US/norm.md)
---

> Supported Languages: [简体中文](https://longbridge.com/zh-CN/quote/VIGL.US/norm.md) | [繁體中文](https://longbridge.com/zh-HK/quote/VIGL.US/norm.md)


# Vigil Neuroscience (VIGL.US) — Financial Reports

## Income Statement (USD)

| Indicator | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
| --- | --- | --- | --- | --- | --- |
| EPS | -0.5600 | -0.4865 | -0.5721 | -0.4746 | -0.5233 |
| ROE | -200.51% | -131.11% | -119.02% | -88.63% | -89.82% |
| Revenue | - | - | - | - | - |
| Net income | -26.66M | -22.41M | -23.83M | -19.26M | -21.23M |

## Balance Sheet (USD)

| Indicator | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
| --- | --- | --- | --- | --- | --- |
| A&L | 86.70M | 107.15M | 117.69M | 131.27M | 108.46M |
| Leverage | 2.10 | 1.65 | 1.64 | 1.48 | 1.27 |
| BVPS | 0.8651 | 1.40 | 1.75 | 2.23 | 2.27 |
| Turnover | - | - | - | - | - |

## Cash Flow Statement (USD)

| Indicator | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
| --- | --- | --- | --- | --- | --- |
| Operating CF | -20.48M | -23.89M | -18.14M | 4.30M | -15.50M |
| Investing CF | 9.80M | 23.23M | 7.83M | -16.58M | 1.04M |
| Financing CF | 273000.00 | 13.27M | 4.44M | 19.86M | 9000.00 |
| Free CF | -11.17M | -16.23M | -9.83M | 10.62M | -7.76M |